Endometrial ablation with a new thermal balloon system.
To assess the efficacy of Thermablate EAS, a new, simple, hand-held, portable endometrial ablation instrument, in the treatment of menorrhagia. Retrospective observational study (Canadian Task Force classification II-1). Urban hospital and private clinic facilities in Bombay, India. Sixteen women with menorrhagia. Endometrial ablation with the Thermablate EAS. Follow-up at 6 months showed eight patients (50%) to have amenorrhea and six (38%) hypomenorrhea. The only failure was in a patient with cystic hyperplasia. No complications occurred. Thermablate EAS is a promising instrument for endometrial ablation.